AQST vs ASML · rev $28.3M vs P/E 57, $665.37B cap
Aquestive Therapeutics Inc (AQST) versus ASML Holding NV ADR (ASML) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
ASML does not have a complete income-statement cache yet.
AQST currently screens at market cap $493.0M. ASML currently screens at market cap $665.37B and trailing P/E 57.5.
Not investment advice. Open the AQST and ASML stock pages for the full models.
Not investment advice.